ATE437176T1 - Gereinigtes hüllprotein eines retrovirus, dafür kodierende nukleinsäuren, vektoren und deren verwendung - Google Patents

Gereinigtes hüllprotein eines retrovirus, dafür kodierende nukleinsäuren, vektoren und deren verwendung

Info

Publication number
ATE437176T1
ATE437176T1 AT03720299T AT03720299T ATE437176T1 AT E437176 T1 ATE437176 T1 AT E437176T1 AT 03720299 T AT03720299 T AT 03720299T AT 03720299 T AT03720299 T AT 03720299T AT E437176 T1 ATE437176 T1 AT E437176T1
Authority
AT
Austria
Prior art keywords
locus
human
receptor encoded
rmc1
polytropic
Prior art date
Application number
AT03720299T
Other languages
English (en)
Inventor
Finn Pedersen
Mogens Duch
Shervin Bahrami
Original Assignee
Retrovec Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Retrovec Aps filed Critical Retrovec Aps
Application granted granted Critical
Publication of ATE437176T1 publication Critical patent/ATE437176T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13045—Special targeting system for viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
    • C12N2810/6045—RNA rev transcr viruses
    • C12N2810/6054—Retroviridae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT03720299T 2002-05-17 2003-05-15 Gereinigtes hüllprotein eines retrovirus, dafür kodierende nukleinsäuren, vektoren und deren verwendung ATE437176T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200200767 2002-05-17
PCT/DK2003/000326 WO2003097674A1 (en) 2002-05-17 2003-05-15 A purified polypeptide, isolated nucleic acids encoding said polypeptide, vectors and use thereof

Publications (1)

Publication Number Publication Date
ATE437176T1 true ATE437176T1 (de) 2009-08-15

Family

ID=29433049

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03720299T ATE437176T1 (de) 2002-05-17 2003-05-15 Gereinigtes hüllprotein eines retrovirus, dafür kodierende nukleinsäuren, vektoren und deren verwendung

Country Status (8)

Country Link
US (1) US20060084791A1 (de)
EP (1) EP1511767B1 (de)
AT (1) ATE437176T1 (de)
AU (1) AU2003223938A1 (de)
CA (1) CA2524892A1 (de)
DE (1) DE60328491D1 (de)
DK (1) DK1511767T3 (de)
WO (1) WO2003097674A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1441900A (en) * 1998-10-01 2000-04-17 University Of Southern California Gene delivery system and methods of use
WO2007107156A2 (en) * 2006-03-17 2007-09-27 Aarhus Universitet Chimeric viral envelopes
JP6419706B2 (ja) 2012-10-25 2018-11-07 トカジェン インコーポレーテッド ミニプロモーターカセットを含むレトロウイルスベクター

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0742831B1 (de) * 1994-01-27 2004-09-29 The Regents Of The University Of Minnesota Nicht humane, transgenische säugetiere mit sich entwickelnder neurologischer krankheit
GB9412844D0 (en) * 1994-06-27 1994-08-17 Medical Res Council Improvements in or relating to therapeutic methods
UA83458C2 (uk) * 2000-09-18 2008-07-25 Байоджен Айдек Ма Інк. Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)

Also Published As

Publication number Publication date
WO2003097674A1 (en) 2003-11-27
EP1511767A1 (de) 2005-03-09
EP1511767B1 (de) 2009-07-22
AU2003223938A1 (en) 2003-12-02
DK1511767T3 (da) 2009-11-23
CA2524892A1 (en) 2003-11-27
DE60328491D1 (de) 2009-09-03
US20060084791A1 (en) 2006-04-20

Similar Documents

Publication Publication Date Title
Lavillette et al. The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors
Jayakar et al. Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release
Lee et al. Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles
Strack et al. Late assembly domain function can exhibit context dependence and involves ubiquitin residues implicated in endocytosis
EP2359851A3 (de) MVA-exprimierende modifizierte HIV-Hüll-, GAG- und POL-Gene
Emerson et al. Identification of the cellular prohibitin 1/prohibitin 2 heterodimer as an interaction partner of the C-terminal cytoplasmic domain of the HIV-1 glycoprotein
Lavillette et al. Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein
ATE286978T1 (de) Rekombinante hiv-2 antigenen, abgeleitete aus synthetischen dns
Checkley et al. Reevaluation of the requirement for TIP47 in human immunodeficiency virus type 1 envelope glycoprotein incorporation
DE59504181D1 (de) Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
NO20025153L (no) Fremgangsmåter og sammensetninger for å påvirke formering av HIV-1, HIV-2 og SIV
EP2339010A3 (de) Gegenüber Komplement-Inaktivierung resistente Lentivirusvektorpartikel
DE3855134D1 (de) Monoklonale menschliche antikörper gegen hiv-i
ATE233821T1 (de) Poxvirusvektoren und deren anwendung als impstoff gegen katzenansteckende peritonitis- viruskrankheit
ATE474850T1 (de) Analoga von peptiden der relaxin-superfamilie
EP1186655A4 (de) Verpackungszelle
Pinón et al. An antiviral peptide targets a coiled-coil domain of the human T-cell leukemia virus envelope glycoprotein
ATE437176T1 (de) Gereinigtes hüllprotein eines retrovirus, dafür kodierende nukleinsäuren, vektoren und deren verwendung
WO2002002738A3 (en) Host cells containing multiple integrating vectors
Manrique et al. Mutational analysis of the feline immunodeficiency virus matrix protein
Manrique et al. Positive and negative modulation of virus infectivity and envelope glycoprotein incorporation into virions by amino acid substitutions at the N terminus of the simian immunodeficiency virus matrix protein
CY1106691T1 (el) Πρωτεϊνη του καψιδιου ιου/χιμαιρες υποδοχεα και μεθοδοι χρησης
Doyle et al. Regions required for CD4 binding in the external glycoprotein gp120 of simian immunodeficiency virus
JP2002508975A (ja) レトロウイルスエンベロープの融合原性を改良するためのプロリン豊富配列の使用
ES2058565T3 (es) Retrovirus recombinante defectivo, su aplicacion en la integracion de secuencias que codifican proteinas determinadas en el genoma de cultivos celulares infectables por el retrovirus salvaje correspondiente y adns recombinantes para la produccion de dicho retrovirus recombinante.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties